Modified cisplatin-based transcatheter arterial chemoembolization for large hepatocellular carcinoma: Multivariate analysis of predictive factors for tumor response and survival in a 163-patient cohort

Journal of Vascular and Interventional Radiology

Volumn 24, Issue 11, 2013, Pages 1639-1646

  Yoon, Hee Mang ^a   Kim, Jin Hyoung ^a   Kim, Eun Joung ^a   Gwon, Dong Il ^a   Ko, Gi Young ^a   Ko, Heung Kyu ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHEMOEMBOLIZATION; CHOLECYSTITIS; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; LIVER ABSCESS; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; METASTASIS; PARTIAL HEPATECTOMY; PLEURA EFFUSION; PORTAL VEIN; POSTEMBOLIZATION SYNDROME; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME; TREATMENT RESPONSE; TUMOR INVASION; TUMOR THROMBUS; TUMOR VOLUME;

AFP; BARCELONA CLINIC LIVER CANCER; BCLC; HAZARD RATIO; HCC; HEPATOCELLULAR CARCINOMA; HR; PORTAL VEIN; PV; RADIATION THERAPY; RADIOFREQUENCY; RF; RT; Α-FETOPROTEIN;

AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; CHEMOEMBOLIZATION, THERAPEUTIC; CISPLATIN; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASMS, MULTIPLE PRIMARY; ODDS RATIO; PORTAL VEIN; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 84886950020     PISSN: 10510443     EISSN: 15357732     Source Type: Journal    
DOI: 10.1016/j.jvir.2013.06.017     Document Type: Article

References (46)

1. J.M. Llovet, M.I. Real, and X. Montana Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial Lancet 359 2002 1734 1739
2. L. Llado, J. Virgili, and J. Figueras A prognostic index of the survival of patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization Cancer 88 2000 50 57
3. M. Minagawa, and M. Makuuchi Treatment of hepatocellular carcinoma accompanied by portal vein tumor thrombus World J Gastroenterol 12 2006 7561 7567
4. J.M. Llovet, and J. Bruix Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival Hepatology 37 2003 429 442
5. J.W. Chung, J.H. Park, and J.K. Han Hepatic tumors: Predisposing factors for complications of transcatheter oily chemoembolization Radiology 198 1996 33 40
6. G.E. Chung, J.H. Lee, and H.Y. Kim Transarterial chemoembolization can be safely performed in patients with hepatocellular carcinoma invading the main portal vein and may improve the overall survival Radiology 258 2011 627 634
7. J.H. Kim, H.K. Yoon, and S.Y. Kim Transcatheter arterial chemoembolization vs. chemoinfusion for unresectable hepatocellular carcinoma in patients with major portal vein thrombosis Aliment Pharmacol Ther 29 2009 1291 1298
8. S. Roayaie, J.S. Frischer, and S.H. Emre Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters Ann Surg 235 2002 533 539
9. K. Takayasu, S. Arii, and I. Ikai Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients Gastroenterology 131 2006 461 469
10. S. Miyayama, M. Yamashiro, and M. Okuda Chemoembolization for the treatment of large hepatocellular carcinoma J Vasc Interv Radiol 21 2010 1226 1234
11. D.B. Brown, J.E. Gould, and D.A. Gervais Transcatheter therapy for hepatic malignancy: standardization of terminology and reporting criteria J Vasc Interv Radiol 20 suppl 2009 S425 S434
12. J.H. Shim, K.M. Kim, and Y.J. Lee Complete necrosis after transarterial chemoembolization could predict prolonged survival in patients with recurrent intrahepatic hepatocellular carcinoma after curative resection Ann Surg Oncol 17 2010 869 877
13. H.T. Hu, J.H. Kim, and L.S. Lee Chemoembolization for hepatocellular carcinoma: multivariate analysis of predicting factors for tumor response and survival in a 362-patient cohort J Vasc Interv Radiol 22 2011 917 923
14. R. Lencioni, and J.M. Llovet Modified RECIST (mRECIST) assessment for hepatocellular carcinoma Semin Liver Dis 30 2010 52 60
15. J.Y. Choi Treatment algorithm for intermediate and advanced stage hepatocellular carcinoma: Korea Oncology 81 suppl 1 2011 141 147
16. S.P. Kalva, M. Pectasides, and K. Yeddula Factors affecting survival following chemoembolization with doxorubicin-eluting microspheres for inoperable hepatocellular carcinoma J Vasc Interv Radiol 24 2013 257 265
17. A. Forner, J.M. Llovet, and J. Bruix Hepatocellular carcinoma Lancet 379 2012 1245 1255
18. H.J. Prajapati, R. Dhanasekaran, and B.F. El-Rayes Safety and efficacy of doxorubicin drug-eluting bead transarterial chemoembolization in patients with advanced hepatocellular carcinoma J Vasc Interv Radiol 24 2013 307 315
19. M. Pinter, F. Hucke, and I. Graziadei Advanced-stage hepatocellular carcinoma: transarterial chemoembolization versus sorafenib Radiology 263 2012 590 599
20. M.T. Sellers, S. Huggins, and K. Kegley Multivariate analysis of prognostic factors for survival following doxorubicin-eluting bead transarterial chemoembolization for hepatocellular carcinoma J Vasc Interv Radiol 24 2013 647 654
21. O.M. Ebied, M.P. Federle, and B.I. Carr Evaluation of responses to chemoembolization in patients with unresectable hepatocellular carcinoma Cancer 97 2003 1042 1050
22. Predictive factors for long term prognosis after partial hepatectomy for patients with hepatocellular carcinoma in Japan. The Liver Cancer Study Group of Japan. Cancer 1994; 74:2772-2780
23. S.A. Shah, A.C. Wei, and S.P. Cleary Prognosis and results after resection of very large (> or = 10 cm) hepatocellular carcinoma J Gastrointest Surg 11 2007 589 595
24. T. Shuto, K. Hirohashi, and S. Kubo Efficacy of major hepatic resection for large hepatocellular carcinoma Hepatogastroenterology 46 1999 413 416
25. R.T. Poon, S.T. Fan, and J. Wong Selection criteria for hepatic resection in patients with large hepatocellular carcinoma larger than 10 cm in diameter J Am Coll Surg 194 2002 592 602
26. K. Osuga, A.A. Khankan, and S. Hori Transarterial embolization for large hepatocellular carcinoma with use of superabsorbent polymer microspheres: initial experience J Vasc Interv Radiol 13 2002 929 934
27. H. Takaki, K. Yamakado, and J. Uraki Radiofrequency ablation combined with chemoembolization for the treatment of hepatocellular carcinomas larger than 5 cm J Vasc Interv Radiol 20 2009 217 224
28. G.D. Dodd, M.C. Soulen, and R.A. Kane Minimally invasive treatment of malignant hepatic tumors: at the threshold of a major breakthrough Radiographics 20 2000 9 27
29. J.M. Llovet, and J. Bruix Novel advancements in the management of hepatocellular carcinoma in 2008 J Hepatol 48 suppl 1 2008 S20 S37
30. T. Livraghi, S.N. Goldberg, and S. Lazzaroni Hepatocellular carcinoma: radiofrequency ablation of medium and large lesions Radiology 214 2000 761 768
31. J.W. Kim, J.H. Kim, and H.J. Won Hepatocellular carcinomas 2-3 cm in diameter: transarterial chemoembolization plus radiofrequency ablation vs. radiofrequency ablation alone Eur J Radiol 81 2012 e189 e193
32. M. Morimoto, K. Numata, M. Kondou, A. Nozaki, S. Morita, and K. Tanaka Midterm outcomes in patients with intermediate-sized hepatocellular carcinoma: a randomized controlled trial for determining the efficacy of radiofrequency ablation combined with transcatheter arterial chemoembolization Cancer 116 2010 5452 5460
33. J.H. Kim, H.J. Won, and Y.M. Shin Medium-sized (3.1-5.0 cm) hepatocellular carcinoma: transarterial chemoembolization plus radiofrequency ablation versus radiofrequency ablation alone Ann Surg Oncol 18 2011 1624 1629
34. M. Zhao, J.P. Wang, and W. Li Comparison of safety and efficacy for transcatheter arterial chemoembolization alone and plus radiofrequency ablation in the treatment of single branch portal vein tumor thrombus of hepatocellular carcinoma and their prognosis factors Zhonghua Yi Xue Za Zhi 91 2011 1167 1172
35. W.Z. Fan, J.Y. Yang, and M.D. Lu Transcatheter arterial chemoembolization plus percutaneous thermal ablation in large hepatocellular carcinoma: clinical observation of efficacy and predictors of prognostic factors Zhonghua Yi Xue Za Zhi 91 2011 2190 2194
36. M. Maluccio, A.M. Covey, and R. Gandhi Comparison of survival rates after bland arterial embolization and ablation versus surgical resection for treating solitary hepatocellular carcinoma up to 7 cm J Vasc Interv Radiol 16 2005 955 961
37. C.D. Lu, S.Y. Peng, X.C. Jiang, Y. Chiba, and N. Tanigawa Preoperative transcatheter arterial chemoembolization and prognosis of patients with hepatocellular carcinomas: retrospective analysis of 120 cases World J Surg 23 1999 293 300
38. W.Y. Lau Lai ECH. Salvage surgery following downstaging of unresectable hepatocellular carcinoma - a strategy to increase respectability Ann Surg Oncol 14 2008 3301 3309
39. M. Ravaioli, G.L. Grazi, and F. Piscaglia Liver transplantation for hepatocellular carcinoma: results of down-staging in patients initially outside the Milan selection criteria Am J Transplant 8 2008 2547 2557
40. F.Y. Yao, R.K. Kerlan, and R. Hirose Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis Hepatology 48 2008 819 827
41. C. Toso, G. Mentha, N.M. Kneteman, and P. Majno The place of downstaging for hepatocellular carcinoma J Hepatol 52 2010 930 936
42. S.M. Yoon, Y.S. Lim, and H.J. Won Radiotherapy plus transarterial chemoembolization for hepatocellular carcinoma invading the portal vein: long-term patient outcomes Int J Radiat Oncology Biol Phys 82 2012 2004 2011
43. J.M. Llovet, A.M. Di Bisceglie, and J. Bruix Design and end points of clinical trials in hepatocellular carcinoma J Natl Cancer Inst 100 2008 698 711
44. A.L. Cheng, Y.K. Kang, and Z. Chen Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: A phase III randomized, double-blind, placebo-controlled trial Lancet Oncol 10 2009 25 34
45. J.M. Llovet, S. Ricci, and V. Mazzaferro Sorafenib in advanced hepatocellular carcinoma N Engl J Med 359 2008 378 390
46. K. Yamada, K. Izaki, and K. Sugimoto Prospective trial of combined transcatheter arterial chemoembolization and three-dimensional conformal radiotherapy for portal vein tumor thrombus in patients with unresectable hepatocellular carcinoma Int J Radiat Oncol Biol Phys 57 2003 113 119